Ondine Biomedical Inc.
OBIMF
$0.14
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.54M | -4.38M | -4.05M | -4.16M | -2.84M |
| Total Depreciation and Amortization | 112.00K | 108.00K | 100.40K | 103.00K | 103.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.80K | 142.50K | 269.70K | 276.80K | 137.00K |
| Change in Net Operating Assets | 601.70K | 580.10K | 676.50K | 694.30K | 6.90K |
| Cash from Operations | -3.68M | -3.54M | -3.00M | -3.08M | -2.59M |
| Capital Expenditure | -8.70K | -8.40K | 0.00 | 0.00 | -3.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.70K | -8.40K | 0.00 | 0.00 | -3.70K |
| Total Debt Issued | -- | -- | 826.00K | 826.00K | -- |
| Total Debt Repaid | -109.00K | -109.00K | -370.00K | -370.00K | -112.00K |
| Issuance of Common Stock | 2.89M | 2.89M | 8.46M | 8.46M | 3.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.00K | -11.00K | -690.50K | -690.50K | -275.00K |
| Cash from Financing | 2.00M | 1.93M | 5.88M | 6.03M | 1.93M |
| Foreign Exchange rate Adjustments | 112.00K | 108.00K | 182.20K | 187.00K | 15.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.57M | -1.52M | 3.06M | 3.14M | -646.00K |